BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11816247)

  • 1. Amphotericin B in lung transplant recipients.
    Klepser ME
    Ann Pharmacother; 2002 Jan; 36(1):167-9. PubMed ID: 11816247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
    Husain S; Capitano B; Corcoran T; Studer SM; Crespo M; Johnson B; Pilewski JM; Shutt K; Pakstis DL; Zhang S; Carey ME; Paterson DL; McCurry KR; Venkataramanan R
    Transplantation; 2010 Dec; 90(11):1215-9. PubMed ID: 20881664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.
    Monforte V; Ussetti P; López R; Gavaldà J; Bravo C; de Pablo A; Pou L; Pahissa A; Morell F; Román A
    J Heart Lung Transplant; 2009 Feb; 28(2):170-5. PubMed ID: 19201343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
    Monforte V; López-Sánchez A; Zurbano F; Ussetti P; Solé A; Casals C; Cifrian J; de Pablos A; Bravo C; Román A
    J Heart Lung Transplant; 2013 Mar; 32(3):313-9. PubMed ID: 23332731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.
    Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Ussetti P; Solé J; Gavaldá J; Roman A
    Transpl Int; 2016 Jan; 29(1):51-62. PubMed ID: 26339864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis.
    Reichenspurner H; Gamberg P; Nitschke M; Valantine H; Hunt S; Oyer PE; Reitz BA
    Transplant Proc; 1997; 29(1-2):627-8. PubMed ID: 9123449
    [No Abstract]   [Full Text] [Related]  

  • 9. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
    Perfect JR; Dodds Ashley E; Drew R
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S207-10. PubMed ID: 15546119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
    Marra F; Partovi N; Wasan KM; Kwong EH; Ensom MH; Cassidy SM; Fradet G; Levy RD
    Ann Pharmacother; 2002 Jan; 36(1):46-51. PubMed ID: 11816256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
    Lowry CM; Marty FM; Vargas SO; Lee JT; Fiumara K; Deykin A; Baden LR
    Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
    Palmer SM; Drew RH; Whitehouse JD; Tapson VF; Davis RD; McConnell RR; Kanj SS; Perfect JR
    Transplantation; 2001 Aug; 72(3):545-8. PubMed ID: 11502995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
    Mohammad RA; Klein KC
    Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case report of pulmonary aspergillosis in lung transplant recipient successfully treated with inhalation administration of liposomal amphotericin B].
    Fujita M; Yanagisawa J; Hiratsuka M; Shiraishi T; Hirano R; Matsumoto T; Shiraishi M; Iwasaki A; Watanabe K
    Jpn J Antibiot; 2013 Feb; 66(1):37-43. PubMed ID: 23777015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
    He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
    Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
    Castagnola E; Moresco L; Cappelli B; Cuzzubbo D; Moroni C; Lanino E; Faraci M
    J Chemother; 2007 Jun; 19(3):339-42. PubMed ID: 17594932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized antifungal prophylaxis: the winds of change?
    Perfect JR
    Clin Infect Dis; 2008 May; 46(9):1409-11. PubMed ID: 18419444
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
    Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia.
    Myers SE; Devine SM; Topper RL; Ondrey M; Chandler C; O'Toole K; Williams SF; Larson RA; Geller RB
    Leuk Lymphoma; 1992 Oct; 8(3):229-33. PubMed ID: 1490149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.
    Behre GF; Schwartz S; Lenz K; Ludwig WD; Wandt H; Schilling E; Heinemann V; Link H; Trittin A; Boenisch O
    Ann Hematol; 1995 Dec; 71(6):287-91. PubMed ID: 8534760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.